Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;38(3):299-303.
doi: 10.1177/19714009241303077. Epub 2024 Nov 20.

Radiology-pathology correlation: Rosai-Dorfman disease

Affiliations
Review

Radiology-pathology correlation: Rosai-Dorfman disease

John C Benson et al. Neuroradiol J. 2025 Jun.

Abstract

Rosai-Dorfman Disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare non-Langerhans cell histiocytic neoplasm. Although the disease classically presents as massive painless lymphadenopathy in young adults, RDD can also involve the central nervous system in some patients. CNS lesions, can cause headaches, neurologic deficits, and even neurologic deficits. The imaging appearance of CNS RDD typically mimics that of meningiomas: well-circumscribed dural-based lesions that often have dural tails. However, some imaging clues also exist that might help a radiologist recognize RDD, even before histopathologic confirmation. This radiology-pathology report of a patient with CNS RDD highlights the most pertinent clinical, imaging, and pathologic features of CNS RDD, and discusses what the neuroradiologist needs to know about the disease.

Keywords: MRI; Tumor; pathology.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Intracranial involvement of disease. Axial fat-saturated post-contrast T1WI (A and B) show diffuse smooth pachymeningeal enhancement over the convexities (long solid arrows), and falx (short arrows). A nodular mass in the left aspect of the foramen magnum (curved arrow) encases the left vertebral artery (dashed arrow). Coronal post-contrast images (C) demonstrate more nodular enhancement along the cavernous sinuses and suprasellar region (long arrows), as well as enhancement along the falx (short arrow). The nodular arrows are hypointense on T2 weighted images (long arrows, D).
Figure 2.
Figure 2.
Extracranial disease. Axial fat-saturated post-contrast T1WI (A) show a large expansile and heterogeneously enhancing mass in the right maxillary sinus that extends into the right inferior turbinate (between straight solid long arrows). On coronal fat-saturated T2WI (B), both the mass (straight solid long arrows) and additional involvement of the left inferior turbinate (dashed straight arrows) are seen. The mass is FDG-avid, seen on both whole-body PET imaging (C) and fused axial PET/CT images (D) (solid curved arrows on both). FDG avidity was also seen in the areas of nodular pachymeningeal disease (not shown). Pachymeningeal enhancement was seen extending from the retroclival region into the ventral and dorsal aspects of the upper cervical spine (short arrows, E). A tiny focus of enhancement along a cauda equina nerve root was seen in the lumbar spine (dashed curve arrow, F).
Figure 3.
Figure 3.
The prior skin biopsy (performed 17 years prior to presentation) showed a dense dermal and subcutaneous lymphoplasmacytic infiltrate with numerous large histiocytes (panel A), immunoreactive for S100 (panel B) and the histiocytic marker CD68/PGM1 (panel C). The low power inset in B highlights the nodular arrangement of the histiocytes, which were negative for CD1a (not shown). The recent biopsy from the left C1 cervical meninges showed a dense atypical histiocytic infiltration in a background of marked chronic lymphoplasmacytic inflammation and dense fibrosis (panel D). Panels E & F illustrate, respectively, S100 and the histiocytic marker CD163.
Figure 4.
Figure 4.
Schematic of typical intracranial findings in Rosai–Dorfman Disease (RDD). As seen in the index case, RDD is often characterized by diffuse dural thickening and/or dural masses, with particular proclivity for the suprasellar, cavernous sinus, and petroclival regions.

References

    1. Torp SH, Solheim O, Skjulsvik AJ. The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know—a minireview. Acta Neurochir 2022; 164(9): 2453–2464. DOI: 10.1007/s00701-022-05301-y. - DOI - PMC - PubMed
    1. Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol 2020; 73(11): 697–705. DOI: 10.1136/jclinpath-2020-206733. - DOI - PubMed
    1. Mahzoni P, Zavareh MHT, Bagheri M, et al. Intracranial ROSAI-DORFMAN disease. J Res Med Sci 2012; 17(3): 304–307. - PMC - PubMed
    1. Elbaz Younes I, Sokol L, Zhang L. Rosai-dorfman disease between proliferation and neoplasia. Cancers 2022; 14(21): 5271. DOI: 10.3390/cancers14215271. - DOI - PMC - PubMed
    1. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016; 127(22): 2672–2681. DOI: 10.1182/blood-2016-01-690636. - DOI - PMC - PubMed

LinkOut - more resources